Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jan 12;16(1):e0238662. doi: 10.1371/journal.pone.0238662

The role of partner influence in contraceptive adoption, discontinuation, and switching in a nationally representative cohort of Ugandan women

Dana O Sarnak 1,*, Shannon N Wood 1, Linnea A Zimmerman 1, Celia Karp 1, Fredrick Makumbi 2, Simon P S Kibira 3, Caroline Moreau 1,4
Editor: Kannan Navaneetham5
PMCID: PMC7802956  PMID: 33434205

Abstract

Background

Understanding contraceptive use dynamics is critical to addressing unmet need for contraception. Despite evidence that male partners may influence contraceptive decision-making, few studies have prospectively examined the supportive ways that men influence women’s contraceptive use and continuation.

Objective

This study sought to understand the predictive effect of partner influence, defined as partner’s fertility intentions and support for contraception, and discussions about avoiding pregnancy prior to contraceptive use, on contraceptive use dynamics (continuation, discontinuation, switching, adoption) over a one-year period.

Methods

This study uses nationally representative longitudinal data of Ugandan women aged 15–49 collected in 2018–2019 (n = 4,288 women baseline; n = 2,755 women one-year follow-up). Two analytic sub-samples of women in union and in need of contraception at baseline were used (n = 618 contraceptive users at baseline for discontinuation/switching analysis; n = 687 contraceptive non-users at baseline for adoption analysis). Primary dependent variables encompassed contraceptive use dynamics (continuation, discontinuation, switching, and adoption); three independent variables assessed partner influence. For each sub-sample, bivariate associations explored differences in sociodemographic and partner influences by contraceptive dynamics. Multinomial regression models were used to examine discontinuation and switching for contraceptive users at baseline; logistic regression identified predictors of contraceptive adoption among non-users at baseline.

Results

Among users at baseline, 26.3% of women switched methods and 31.5% discontinued contraceptive use by follow-up. Multinomial logistic regression, adjusting for women’s characteristics, indicated the relative risk of contraceptive discontinuation doubled when women did not discuss pregnancy avoidance with their partner prior to contraceptive use. Partner influence was not related to method switching. Among non-users at baseline, partner support for future contraceptive use was associated with nearly three-fold increased odds of contraceptive adoption.

Significance

These results highlight the potentially supportive role of male partners in contraceptive adoption. Future research is encouraged to elucidate the complex pathways between couple-based decision-making and contraceptive dynamics through further prospective studies.

Introduction

With rapid increases in contraceptive coverage, there is growing interest in examining contraceptive use dynamics, particularly discontinuation, which increasingly contributes to unmet need for family planning. Global estimates using the Demographic and Health Survey (DHS) data from 34 low- and middle-income countries (LMICs) suggest that 38% of unmet need for contraception is attributable to the discontinuation of contraceptive methods while still stating a desire to avoid pregnancy [1]. Additionally, contraceptive discontinuation is estimated to account for one-third of unintended pregnancies [2]. In LMICs, contraceptive discontinuation is relatively common [3, 4], and varies by a range of factors, including method type, user characteristics and circumstances, and the quality of contraceptive counseling [57]. Similar factors also shape contraceptive adoption [8, 9], which importantly addresses access to contraception and method satisfaction of new users.

To date, the majority of research on determinants of contraceptive dynamics has focused on women’s characteristics. Less attention has been given to partner-related influences, despite theoretical justification for their investigation. For example, Miller et al. propose that each partner’s fertility intentions are influenced by individual desires, as well as the perceived desires of the other partner, and both may be continually moderated by spousal communication [10]. They posit that in cases where there is disagreement, the weight of each partner may not be equal in deciding the final reproductive behavior [10]. As such, most research on partner dynamics has primarily examined partners as barriers to contraceptive use, using rationales such as the Theory of Gender and Power, which specifies the potential impact of gender inequities across labor, power, and relationship domains [11]; these inequities have a cascading impact on women’s health, including their access to and use of contraception [12, 13]. Studies in the United States, and more recently within LMICs, have examined partner-perpetrated reproductive coercion as influencing contraceptive non-use and subsequent unintended pregnancy [1416]. This research has generally not been framed to examine a more extensive range of partner roles, including the potential influence of partner support on contraceptive dynamics, though this substantive focus is growing [1719].

Moreover, quantitative studies examining partner influence on women’s contraceptive use in LMICs tend to conflict with qualitative narratives, further obscuring this relationship. Few nationally representative quantitative studies have examined partner influence outside of cross-sectional surveys, such as the DHS, which indicate that partner opposition is an infrequently reported reason for non-use of contraception. For example, among women with an unmet need for contraception, the percentage of women who reported that their primary reason for non-use was partner opposition was only 3.8% in Latin American and the Caribbean, 11.2% in Asia, and 9.5% in Africa [20]. Similar to reasons for contraceptive non-use, few women report discontinuation of contraceptive methods due to husband opposition. Among recent DHS surveys in sub-Saharan Africa, discontinuation due to husband opposition ranged from 1% in Ethiopia (2016) to 9.9% in Guinea (2018) [21]. Despite these quantitative findings, a growing evidence base from qualitative studies conducted in LMICs has focused on how partners may inhibit women’s contraceptive use [17, 2226]. These studies indicate women’s preference to use contraception covertly if faced with partner opposition, however, they have mostly explored partners as barriers to contraceptive use and do not probe more extensively on experiences with partners as potential enablers to using contraception.

The different perspectives offered from large-scale quantitative surveys relative to more specific qualitative research raise a number of concerns regarding measurement and conceptualization of partner influence in large-scale surveys. Some studies suggest that partner opposition may be underreported, thereby attenuating its measured impact on contraceptive use [18,19]. Large-scale surveys, including the DHS, compute discontinuation rates using only the primary reason for discontinuation; this analytic approach may reduce the proportion of discontinuation due to husband opposition, as many women also report desires to get pregnant or concerns about side-effects/health concerns as their primary reason for discontinuation.

Beyond measurement issues, the widespread focus on partner opposition, while critical to address from a human rights and public health perspective, only captures one end of a spectrum of partner influences; this narrow scope omits the potential for examination of positive partner influences on women’s adoption and continuation of contraception. Partner support is not just the lack of opposition—recent cross-sectional studies have examined the positive roles male partners may play in contraceptive decision-making. One study among pregnant women in rural Ghana found that perceived partner acceptability of family planning was one of the strongest predictors of the intention to use family planning in the future [27]. Another study of pregnant women and their partners in southeast Nigeria showed that men who stated support for their spouses’ use of contraception were more likely to have spouses who intended to use contraception in the future [28]. Both studies highlight the central role of partner support in contraceptive decision-making, however they examine intent to use contraception, rather than contraceptive use. Qualitative data from South Africa have contextualized findings of quantitative studies by highlighting the supportive roles men play in facilitating access to family planning clinics, initiating contraceptive use, or improving adherence to methods and scheduled visits [17]. To date, only one longitudinal study conducted in Ghana linked spousal communication prospectively with contraceptive use, yet this study was not designed to be nationally representative [29].

Given the importance of gender and partner dynamics in reproductive decision-making, this study seeks to understand the predictive effect of partner influences, including partner support for contraception, discussions with partners about avoiding pregnancy prior to use, and perceived partner fertility intentions, on women’s contraceptive use dynamics (adoption, discontinuation, and switching) over a one-year period in a nationally representative sample in Uganda. As programs continue to expand the emphasis on male engagement in family planning services, understanding the role of partner support in contraceptive dynamics will be crucial. Messages and interventions should be tailored to specific contraceptive dynamics to focus not only on addressing contraceptive discontinuation, but also on increasing adoption and continuation.

Methods

Study design

Longitudinal data for this analysis came from Performance Monitoring and Accountability 2020’s (PMA2020) Uganda Round 6 survey (herein referred to as baseline), fielded in April-May 2018, with follow-up data from the Round 6 Follow-up Study (herein referred to as follow-up) conducted in May-June 2019. PMA2020 is a nationally representative, multi-stage, cluster survey of women aged 15–49. At baseline, 110 enumeration areas (EAs; geographical areas of approximately 200 households defined by the census), were selected using probability proportional-to-size sampling; all occupied households in the selected areas were enumerated. Forty-four households were randomly selected within each EA, and after completing a household survey, all women age 15–49 who were either usual members of the selected households or who slept in the household the night prior were approached for interview. After eligibility was confirmed, women were asked to complete written consent; if the woman agreed to participate, she was then interviewed by a trained resident interviewer. For unmarried women aged 15–17, written consent was first obtained from a parent or legal guardian prior to the women providing written assent to participate. Further information on the methodological design of PMA2020 cross-sectional surveys is available from www.pmadata.org and Zimmerman et al. [30].

A total sample of 4,288 women were interviewed at baseline. At time of interview, women were asked to consent for follow up, of which 4,095 agreed (95.4%). A total of 2,755 women were re-interviewed at follow-up (follow-up rate = 67.2%; Fig 1).

Fig 1. Analytic sub-samples.

Fig 1

Baseline face-to-face interviews collected a range of information on women’s sociodemographic characteristics, reproductive history, fertility status and intentions, and contraceptive behaviors. Women were also asked about their partners’ fertility intentions and support of family planning. The follow-up survey focused on pregnancy intentions and outcomes, and contraceptive behaviors since the baseline interview.

All data collection procedures were approved by Institutional Review Boards (IRBs) at the Makerere University School of Public Health (HDREC 081) and Uganda National Council for Science and Technology (SS3400) in Kampala, Uganda, and the Johns Hopkins Bloomberg School of Public Health in Baltimore, USA.

Analytic samples

Fig 1 shows a flow chart of the inclusion and exclusion criteria used to produce the two analytic samples included in this study. Both samples selected women who completed baseline and follow up-surveys and were in union at baseline; samples excluded women who did not have a partner or husband (n = 756). Women were also excluded if, at baseline, they were pregnant (n = 304), sterilized (n = 56), or indicated they were infertile (n = 54). In addition, women who reported wanting a child in the next year were excluded, as they would not be in need of contraception (n = 280). The analytic sample for the contraceptive discontinuation/switching analysis included 618 users of reversible contraception, including traditional method users, at baseline. The analytic sample for the contraceptive adoption analysis included 687 women who were not using contraception at baseline.

Loss-to-follow-up weights

Due to potential bias from loss-to-follow-up, an inverse propensity score was constructed by estimating a multivariate regression model with women’s age, parity, marital status, schooling, wealth quintile, and residence as covariates. The predicted probability of loss-to-follow-up was then multiplied by the original baseline individual weight and its inverse was applied to re-weight the follow-up responses appropriately. S1 Table compares the responses of the full sample of women at baseline and those that completed follow-up, both weighted and unweighted. While there was differential loss-to-follow-up across sociodemographic characteristics, as well as our independent variables of interest, after adjusting for the predicted probability of loss-to-follow-up, there were no differences in the baseline characteristics of all women in the baseline versus those who were followed-up one year later. These sensitivity analyses indicate that the weighted findings in this analysis can be interpreted to reflect the national characteristics of women of reproductive age for baseline year.

Measures

Primary dependent variables focused on contraceptive dynamics, namely contraceptive continuation, discontinuation, switching, and adoption (defined subsequently). All contraceptive dynamics measures were assessed by comparing women’s contraceptive use status at baseline and follow-up interviews. Contraceptive use status was defined at each survey as the response to the question “Are you or your partner currently doing something or using any method to delay or avoid getting pregnant?” followed by a list of methods, if affirmative.

  • Contraceptive continuation/ discontinuation/ switching: Contraceptive continuation, discontinuation, and switching were assessed only among women who indicated contraceptive use at baseline. Women were defined as “continuers” if they were using the same method at baseline and follow-up, defined as “switchers” if they were using a different method at follow-up than what they reported at baseline, and as “discontinuers” if they reported non-use at follow-up.

  • Contraceptive adoption: Contraceptive adoption was assessed among non-users of contraception at baseline. Women were categorized as “adopters” if they reported using at follow-up or as “continued non-users” if they reported non-use again at follow-up.

Independent variables

Three independent variables of interest were examined separately. All partner characteristics reported were as perceived by the female partner.

Partner support for contraceptive use was assessed using two questions asked at baseline. To assess support of current or future contraceptive use, users of contraception at baseline were asked if their partner was supportive of their contraceptive use; non-users at baseline were asked if their partner would be supportive of them using contraception in the future. Response categories included: yes, no, and don’t know. Women who responded “don’t know” to current contraceptive use support (n = 6) were excluded from regression analyses.

Women’s discussions with their partners surrounding the decision to avoid a pregnancy prior to contraceptive use were examined among all women who were using contraception at baseline. Women were asked if they discussed the decision to avoid a pregnancy with their partner prior to starting their contraceptive method (binary response: yes/no).

Partner’s perceived fertility intentions were assessed at baseline for all women via a single item: “Does your husband/partner want to have a/another child with you within two years? Response categories included: yes, no, and unsure.

Covariates

Sociodemographic covariates at baseline were considered, including women’s age (15–24, 25–34, 35+ years), education (none, primary, secondary+), parity (0–2, 3–4, 5+ children), polygynous relationship, household wealth (quintiles), and residence (urban/rural), which have been shown to be related to contraceptive use. All covariates were modelled as binary or categorical, and small categories were combined given baseline distributions. For parity, nulliparous women were grouped with women who had 1–2 children, given skewedness towards high childbearing.

Analytical approach

First, exploratory analyses assessed the distributions of sociodemographic characteristics and independent variables measuring partner influence (partner support, discussions, and fertility intentions) among each analytic sample.

Second, bivariate associations were conducted among contraceptive users at baseline, showing the percent of women who continued use, switched methods, or who had discontinued at follow-up, across socio-demographic characteristics and partner influences; design-based F statistics were used to detect significant differences between contraceptive continuers, switchers, and discontinuers. The same approach was applied to the study of contraceptive adoption, by examining associations between partner influences, sociodemographic characteristics, and contraceptive adoption at follow-up among women who were not using contraception at baseline. Sensitivity analyses adjusted for method longevity (long vs. short-acting method); however, no significant differences were observed (results not shown).

Among women who were using contraception at baseline, bivariate and multivariable multinomial logistic regressions were conducted to examine the influence of partner fertility intentions and support for contraception, and discussions with a partner to avoid a pregnancy, on contraceptive switching and discontinuation. Adjusted analyses accounted for women’s age, schooling level, parity, polygyny, urban/rural residence, and wealth quintile. Among women who were not using contraception at baseline, bivariate and multivariable logistic regression models estimated the odds ratios of contraceptive adoption at follow-up, according to partner support for future use of contraception and adjusting for the same baseline sociodemographic characteristics.

All analyses were conducted using Stata 16 (College Station, TX), accounting for within-EA clustering effects and multi-stage stratified cluster survey design of PMA, in addition to adjustment for differential loss-to-follow-up using inverse propensity score weights. P-values of <0.05 were considered statistically significant; given sample size limitations, p-values <0.10 were considered marginally significant.

Results

Table 1 describes the characteristics of the two analytic samples at baseline. In terms of contraceptive users at baseline, over two-thirds of women were younger than 35 years (70.4%), almost all had at least a primary school education (93.4%), and the majority lived in rural areas (80.7%). Number of children was evenly split across the three categories: 31% of women reported having 0–2 children, 32% reported 3–4 children, while 37% reported having 5 or more children. Two-thirds of women stated their partners had no other wives. Most contraceptive users at baseline reported using a modem method of contraception (86.8%), stated that their partners supported their use of contraception (83.4%) and that they had discussed the decision to avoid a pregnancy with their partners before starting their current method (82.1%). Approximately 40% of contraceptive users reported that their partners wanted a child within two years and another 42% believed their partners didn’t want a child within two years; the remaining women stated they did not know their partners’ fertility intentions (17.6%).

Table 1. Descriptive characteristics of contraceptive users and non-users at baseline (n = 1,305).

Baseline characteristics Contraceptive status at baseline (%)
Contraceptive users at baseline (n = 618) Contraceptive non-users at baseline (n = 687)
Age 15–24 years 27.2 23.7
25–35 years 43.2 38.6
35 plus years 29.6 37.7
Highest schooling level None 6.6 17.3
Primary 56.2 61.7
Secondary or higher 37.2 21.1
Parity 0–2 children 30.9 26.3
3–4 children 31.9 25.4
5 plus children 37.2 48.3
Partner has other wives No 66.1 63.6
Yes 26.4 32.6
Don’t know 7.6 3.9
Household wealth category Lowest 18.2 32.0
Middle lowest 16.1 23.9
Middle 22.0 18.3
Middle higher 21.8 12.4
Highest 21.9 13.5
Urban residence Yes 19.3 17.6
Type of method used Modern 86.8 --
Traditional 13.3 --
Partner support for current contraceptive use No Support 15.7 --
Support 83.4 --
Don’t know 0.9 --
Discussed decision to avoid pregnancy with partner before method No 17.9 --
Yes 82.1 --
Partner support for future contraceptive use No support for future use -- 37.0
Support for future use -- 54.8
Don’t know -- 8.2
Partner fertility intentions Partner wants child within 2 years 39.9 43.5
Partner doesn’t want child within 2 years 42.5 38.0
Don’t know 17.6 18.5

The characteristics of the non-users at baseline were slightly different (Table 1). Almost two-thirds of the sample were younger than 35 years (62.3%), and while a majority reported at least a primary school education (82.7%), 17.3% had no formal education. Almost half of the non-users at baseline had five or more living children (48.3%). Almost two-thirds of women reported their partners had no other wives (63.6%). Slightly more than half of women stated their partner would be supportive of future contraceptive use (54.8%), while 8.2% were not sure. Over forty percent of users reported that their partners wanted a child within two years, while 38.0% indicated that their partners didn’t want a child within two years; the remaining women were unsure of their partners’ fertility intentions (18.5%).

Table 2 shows the bivariate associations between baseline characteristics and contraceptive use dynamics at follow-up among users at baseline. Overall, 39.1% of women had continued their contraceptive method at follow-up, while 30% had switched methods and 31% had discontinued completely. Parity was the only sociodemographic characteristic significantly associated with switching or discontinuation; women with five or more children showed the highest proportion of continuation (43.5%), while women with fewer children had the highest proportion of discontinuation (40.0%; p = 0.02). Engaging in discussions about avoiding pregnancy prior to initiating contraceptive use was marginally associated with contraceptive dynamics (p = 0.07).

Table 2. Bivariate associations between baseline characteristics and contraceptive status at follow-up, among baseline contraceptive users (n = 618).

Contraceptive status at follow-up
Baseline characteristics Row n Women who continued Women who switched methods Women who discontinued p-value
%
Total n (%) 618 39.1 30.3 30.6
Age 15–24 years 136 35.4 28.0 36.7 0.22
25–35 years 274 36.3 35.0 28.7
35 plus years 208 46.7 25.6 27.7
Highest schooling level None 53 51.8 9.1 39.1 0.07
Primary 376 39.4 28.5 32.1
Secondary or higher 189 36.5 36.8 26.7
Parity 0–2 children 157 28.3 31.7 40.0 0.02
3–4 children 195 44.4 32.6 23.0
5 plus children 266 43.5 27.2 29.3
Partner has other wives No 410 40.3 30.5 29.1 0.94
Yes 167 36.5 30.0 33.5
Don’t know 41 37.3 29.5 33.2
Household wealth category Lowest 134 40.7 25.7 33.6 0.43
Middle lowest 113 33.8 28.3 37.9
Middle 143 34.2 32.7 33.1
Middle higher 108 41.4 36.7 21.9
Highest 120 44.3 26.8 28.8
Residence Urban 122 37.1 39.3 23.6 0.27
Rural 496 39.6 28.2 32.3
Type of method used Modern 537 39.0 30.8 30.2 0.85
Traditional 81 40.0 27.1 32.9
Partner support for current contraceptive use No Support 95 36.7 23.1 40.2 0.32
Support 517 39.5 31.8 28.7
Discussed decision to avoid pregnancy with partner before method No 107 35.0 23.3 41.8 0.07
Yes 510 39.9 31.9 28.2
Partner fertility intentions Partner wants child within 2 years 244 38.0 29.8 32.1 0.89
Partner doesn’t want child within 2 years 265 41.5 29.7 28.8
Don’t know 108 35.9 32.5 31.5

Boldface indicates p<0.05 from design-based F-statistic.

In the adjusted analysis (Table 3), none of the partner influences nor perceptions of partner fertility intentions were related to switching patterns. On the other hand, women who reported having contraceptive use support from their partners had a reduced risk of discontinuing, relative to women who said their partners did not support their contraceptive use, though this association was only marginally significant (aOR = 0.59, p = 0.08). Similarly, participating in discussions about pregnancy avoidance prior to adopting the contraceptive method was significantly associated with a lower risk of discontinuation, relative to women who did not have these discussions with their partners (aOR = 0.55, p = 0.04). Partners’ perceived fertility intentions were not related to either switching or discontinuation.

Table 3. Bivariate and multivariable multinomial regression of contraceptive switching and discontinuation relative to continued use by partner influence, among baseline contraceptive users (n = 618).

Switched Discontinued
Unadjusted Adjusted Unadjusted Adjusted
RRR (95% CI)
Partner support for current contraceptive use
 No support ref ref ref ref
 Support 1.28 (0.60–2.71) 1.59 (0.73–3.49) 0.66 (0.39–1.13) 0.59 (0.33–1.05)
Discussed decision to avoid pregnancy with partner
 No discussion ref ref ref ref
 Discussion 1.20 (0.58–2.49) 1.29 (0.63–2.68) 0.59* (0.35–0.99) 0.55* (0.32–0.96)
Partner fertility intentions
 Wants a child < 2 years ref ref ref ref
 Doesn’t want a child < 2 years 0.91 (0.55–1.50) 0.99 (0.54–1.83) 0.82 (0.45–1.49) 0.89 (0.50–1.57)
 Don’t know 1.16 (0.61–2.18) 1.27 (0.63–2.54) 1.04 (0.54–2.00) 1.16 (0.59–2.28)

Adjusted for age, parity, education, polygyny, residence, and wealth quintile.

p<0.10;

*p<0.05;

**p<0.01;

***p<0.001; Boldface indicates p<0.05.

Factors informing contraceptive adoption are displayed in Table 4. We found that 32.1% of non-users of contraception at baseline had adopted contraception by the follow-up survey. Younger women (age 15–34) had higher proportions of adoption than those aged 35 and above. Similarly, adoption increased with increasing education level. Further, 42.8% of women who reported their partners would support future contraceptive use had adopted a method by follow-up, whereas only 19.5% of those without reported support had started using a method (p<0.001).

Table 4. Bivariate associations between baseline characteristics and contraceptive status at follow-up, among contraceptive non-users at baseline (n = 687).

Contraceptive status at follow-up
Baseline characteristics n Continued non-user Adopters p-value
%
Total n (%) 687 67.9 32.1
Age 15–24 years 137 60.6 39.4 <0.001
25–35 years 253 61.5 38.5
35 plus years 297 79.0 21.0
Highest schooling level None 162 81.4 18.6 0.02
Primary 413 68.2 31.8
Secondary or higher 112 56.0 44.0
Parity 0–2 children 160 68.7 31.3 0.03
3–4 children 170 59.0 41.0
5 plus children 357 72.1 27.9
Partner has other wives No 413 65.3 34.7 0.46
Yes 252 73.3 26.7
Don’t know 22 64.9 35.1
Household wealth category Lowest 268 76.2 23.8 0.11
Middle lowest 158 69.9 30.1
Middle 120 67.8 32.2
Middle higher 76 57.4 42.6
Highest 65 54.2 45.8
Residence Urban 108 63.1 36.9 0.51
Rural 579 68.9 31.1
Partner support for future contraceptive use No support for future use 277 80.5 19.5 <0.001
Support for future use 338 57.2 42.8
Don’t know 64 81.9 18.1
Partner fertility intentions Partner wants child < 2 years 293 69.0 31.0 0.60
Partner doesn’t want child < 2 years 251 65.2 34.8
Don’t know 141 70.4 29.6

Boldface indicates p<0.05 from design-based F-statistic.

In the adjusted logistic regression analysis (Table 5), partner support for future contraceptive use was associated with 2.74 increased odds of adoption compared to those who did not perceive partner support in future contraceptive use (p<0.05). Further, women who reported that their partner did not want a child within two years were more likely to adopt contraception than those who reported that their partner wanted a child soon, although the association did not reach statistical significance (aOR = 1.61, p = 0.09).

Table 5. Bivariate and multivariable logistic regression of contraceptive adoption relative to continued non-use by partner influence, among baseline contraceptive non-users (n = 687).

Unadjusted Adjusted
OR (CI)
Partner support for future contraceptive use
 No support ref ref
 Support 3.10*** (1.86–5.16) 2.74*** (1.48–5.09)
 Don’t know 0.91 (0.33–2.52) 1.15 (0.36–3.62)
Partner’s fertility intentions
 Wants a child within 2 years ref ref
 Doesn’t want a child within 2 years 1.19 (0.75–1.88) 1.61 (0.93–2.78)
 Don’t know 0.94 (0.58–1.50) 1.39 (0.82–2.35)

Adjusted for age, parity, education, polygyny, residence, and wealth quintile.

p<0.10;

*p<0.05;

**p<0.01;

***p<0.001; Boldface indicates p<0.05.

Discussion

Our findings reflect the multi-faceted ways in which partners can influence contraceptive use and provide greater context to the role that partners play in contraceptive adoption, switching, and discontinuation. Specifically, we found that partner support was strongly associated with contraceptive adoption among non-users at baseline, after accounting for demographic characteristics. Among women who were using contraception at baseline, findings suggest that open communication about one’s desire to prevent pregnancy prior to using contraception may support contraceptive continuation. While women’s perceptions of their partners’ fertility intentions were not associated with continued use of contraception, they did appear to marginally affect contraception adoption.

Taken together, these results highlight the important and positive role that partners may play in contraceptive use dynamics. Involving partners in discussions around fertility decisions to delay or limit childbearing may be important components for interventions and programs that aim to improve contraceptive continuation. While these findings are fairly intuitive, few longitudinal studies have prospectively examined these relationships. For example, increased spousal communication around family planning has been linked with higher contraceptive use and lower unmet need [31], however, directionality of this relationship remained unclear. Establishing the temporal relationship between partner influence and contraceptive discontinuation, as demonstrated by the present study, confirms the predictive effect of spousal communication on a nationally representative level in Uganda. Further, these results offer evidence to support interventions that aim to improve communication within couples around childbearing decisions and family planning. Specifically, interventions should aim to combat harmful social norms that may label conversations around contraception as taboo within a couple dyad.

The marginal results on partner support and contraceptive discontinuation and null findings for partner support and switching may suggest that partner influence holds less weight once a woman is already using contraception. Qualitative research among women who use contraception covertly due to partner opposition indicates high motivation for contraceptive use to avoid disclosure [23, 24]. Further, research in both high- and low-income settings indicates that motivations are highly predictive of contraceptive continuation [32, 33]. In the absence of information on the strength of women’s motivations surrounding pregnancy prevention, this analysis could not disentangle partner support from women’s own motivations. Continued research is needed to understand women’s nuanced decision-making practices and their motivations in adopting and continuing contraceptive use, particularly for women who may be unable to garner initial partner support.

This study has several limitations. First, only 67% of the original baseline sample was retained at follow-up, mostly due to loss of women at the household level. While the loss-to-follow-up was differential by expected socio-demographic characteristics (S1 Table), loss-to-follow-up weighting adjustment was able to restore the panel composition to that of the original sample. However, underlying differences between the samples could persist. Further, given low contraceptive prevalence in Uganda, the high loss-to-follow-up observed in our sample restricted the sample sizes for examining contraceptive use dynamics and potentially limited our ability to detect statistically meaningful differences between adopters, discontinuers, and switchers. Moreover, these analyses were limited by measurement issues; as indicated in previous research [3234], the timeframe for partner fertility intentions (two years) did not match the same timeframe as a woman’s own fertility intentions (one year). Lastly, all partner characteristics were reported by the female respondent, rather than by her partner. Few studies have evaluated the accuracy of proxy-partner reporting, especially around family planning and fertility measures, in sub-Saharan African contexts [3538].

Despite these limitations, this study adds to a small, but growing, body of longitudinal evidence on partner influence and contraceptive use dynamics and has meaningful implications for family planning programs and providers. Foremost, interventions should be targeted at both couples and women alone in order to increase uptake of contraception among those seeking it, reduce discontinuation among those still in need, and promote switching where it is sought. These results highlight the benefits of engaging male partners in family planning programs, particularly to facilitate adoption among non-users who want to delay or limit childbearing, as evidenced by decreased adoption among those without partner support (20% vs 43%). Programs that support spousal communication around family planning, avoiding or planning for a pregnancy, and fertility intentions could be key in achieving reproductive goals [3941].

While this study provides some evidence of male partners’ supporting roles, the specifics remain poorly understood. Future research must include men in studies surrounding fertility preferences and views on contraceptive use, rather than assessing solely by women’s reports. Further, this research should seek to understand characteristics of partners who may be supportive of contraceptive use, including individual, couple, family, and contextual factors that promote contraceptive discussions and use. Lastly, a better understanding of the spectrum from partner opposition to support is needed, including reasons for support, non-support, and opposition. Future research will require improved measurement approaches to understand the range of roles that partners play in contraceptive dynamics to further disentangle pathways that may either help or hinder contraceptive use.

Conclusions

Contraceptive use is often a couple-based decision, and while reproductive coercion gravely infringes on women’s health and rights, this research also points to the supportive role of partners in contraceptive decisions. Future research is encouraged to consider the spectrum of partner roles in contraceptive decisions and the factors promoting male positive engagement. While simultaneously ensuring that women’s rights and bodily autonomy are protected, increased male engagement in reproductive health programs may facilitate improved knowledge and healthier couple communication.

Supporting information

S1 Table. Comparison of baseline and follow-up samples with and without loss-to-follow-up weighting.

(DOCX)

Data Availability

Data for this study are publicly available at https://www.pmadata.org/data/available-datasets. Data are free to download and use; users are required to register for a PMA dataset account. The specific datasets used in this study are the Uganda Round 6 (2018) Household & Female survey and the Uganda Round 6 Follow-up (2019) Household & Female survey.

Funding Statement

This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA [OPP1163880; Investigator: AO Tsui]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Jain AK, Obare F, RamaRao S, Askew I. Reducing Unmet Need by Supporting Women With Met Need. Int Perspect Sex Reprod Health. 2013;39: 133–141. 10.1363/3913313 [DOI] [PubMed] [Google Scholar]
  • 2.Jain AK, Winfrey W. Contribution of Contraceptive Discontinuation in 36 Developing Countries. Stud Fam Plann. 2017;48: 269–278. 10.1111/sifp.12023 [DOI] [PubMed] [Google Scholar]
  • 3.Bradley SE., Schwandt H, Khan S. Levels, Trends, and Reasons for Contraceptive Discontinuation. Washington, DC; 2009. [Google Scholar]
  • 4.Tsui AO, Brown W, Li Q. Contraceptive Practice in Sub-Saharan Africa. Popul Dev Rev. 2017;43: 166–191. 10.1111/padr.12051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mack N, Crawford T, Guise J, Chen M, Grey T, Feldblum P, et al. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception (Review). Cochrane Database Syst Rev. 2019. 10.1002/14651858.CD004317.pub5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Blanc A, Curtis S, Croft T. Monitoring Contraceptive Continuation: Links to Fertility Outcomes and Quality of Care. Stud Fam Plann. 2002;33 10.1111/j.1728-4465.2002.00127.x [DOI] [PubMed] [Google Scholar]
  • 7.Ali MM, Cleland J. Contraceptive Switching after Method-related Discontinuation: Levels and Differentials. Stud Fam Plann. 2010;41: 129–133. 10.1111/j.1728-4465.2010.00234.x [DOI] [PubMed] [Google Scholar]
  • 8.Sarnak D, Tsui A, Makumbi F, Kibira SPS, Ahmed S. The predictive utility of unmet need on time to contraceptive adoption: a panel study of non-contracepting Ugandan women. 10.1016/j.conx.2020.100022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mumah JN, Machiyama K, Mutua M, Kabiru CW, Cleland J. Contraceptive Adoption, Discontinuation, and Switching among Postpartum Women in Nairobi’s Urban Slums. Stud Fam Plann. 2015;46: 369–386. 10.1111/j.1728-4465.2015.00038.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Miller WB, Severy LJ, Pasta DJ. A framework for modelling fertility motivation in couples. Popul Stud (NY). 2004;58: 193–205. 10.1080/0032472042000213712 [DOI] [PubMed] [Google Scholar]
  • 11.Wingood GM, Diclemente RJ. Application of the Theory of Gender and Power to Examine HIV-Related Exposures, Risk Factors, and Effective Interventions for Women. Heal Educ Behav. 2000;27: 539–565. 10.1177/109019810002700502 [DOI] [PubMed] [Google Scholar]
  • 12.Okigbo CC, Speizer IS, Domino ME, Curtis SL, Halpern CT, Fotso JC. Gender norms and modern contraceptive use in urban Nigeria: a multilevel longitudinal study. BMC Womens Health. 2018;18: 1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dereuddre R, Buffel V, Bracke P. Power and the gendered division of contraceptive use in Western European couples. Soc Sci Res. 2017;64: 263–276. 10.1016/j.ssresearch.2016.10.004 [DOI] [PubMed] [Google Scholar]
  • 14.Miller E, Decker MR, Mccauley HL, Tancredi DJ, Levenson RR, Waldman J, et al. Pregnancy coercion, intimate partner violence and unintended pregnancy ☆. Contraception. 2010;81: 316–322. 10.1016/j.contraception.2009.12.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Silverman JG, Boyce SC, Dehingia N, Rao N, Chandurkar D, Nanda P, et al. Reproductive coercion in Uttar Pradesh, India: Prevalence and associations with partner violence and reproductive health. SSM—Popul Heal. 2019;9 10.1016/j.ssmph.2019.100484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Silverman JG, Challa S, Boyce SC, Averbach S, Raj A. Associations of reproductive coercion and intimate partner violence with overt and covert family planning use among married adolescent girls in Niger. EClinicalMedicine. 2020;22 10.1016/j.eclinm.2020.100359 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kriel Y, Milford C, Cordero J, Suleman F, Beksinska M, Steyn P, et al. Male partner influence on family planning and contraceptive use: perspectives from community members and healthcare providers in KwaZulu-Natal, South Africa. Reprod Health. 2019;16: 1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gonie A, Wudneh A, Nigatu D, Dendir Z. Determinants of family planning use among married women in bale eco-region, Southeast Ethiopia: a community based study. BMC Womens Health. 2018;18: 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Staveteig S. Fear, opposition, ambivalence, and omission: Results from a follow-up study on unmet need for family planning in Ghana. PLoS One. 2017;12: e0182076 10.1371/journal.pone.0182076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Sedgh G, Hussain R. Reasons for Contraceptive Nonuse among Women Having Unmet Need for Contraception in Developing Countries. Stud Fam Plann. 2014;45: 151–169. 10.1111/j.1728-4465.2014.00382.x [DOI] [PubMed] [Google Scholar]
  • 21.USAID. Demograhic and Health Surveys Stat Compiler. 2020.
  • 22.Kopp DM, Bula A, Maman S, Chinula L, Tsidya M, Mwale M, et al. Influences on birth spacing intentions and desired interventions among women who have experienced a poor obstetric outcome in Lilongwe Malawi: a qualitative study. BMC Pregnancy Childbirth. 2018;18: 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Karp C, Wood SN, Hadiza G, Kibira SPS, Makumbi F, Omoluabi E, et al. “I am the master key that opens and locks”: Presentation and application of a conceptual framework for women’s and girls’ empowerment in reproductive health. Press Soc Sci Med. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kibira SPS, Karp C, Wood SN, Desta S, Galadanci H, Makumbi FE, et al. Covert use of contraception in three sub-Saharan African countries: a qualitative exploration of motivations and challenges. Press BMC Public Heal. 2020. 10.1186/s12889-020-08977-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Obare F, Odwe G, Cleland J. Men’s needs and women’s fears: gender-related power dynamics in contraceptive use and coping with consequences in a rural setting in Kenya. Cult Heal Sex. 2020. [cited 14 Nov 2020]. 10.1080/13691058.2020.1807605 [DOI] [PubMed] [Google Scholar]
  • 26.Harrington EK, Dworkin S, Withers M, Onono M, Kwena Z, Newmann SJ. Gendered power dynamics and women’s negotiation of family planning in a high HIV prevalence setting: a qualitative study of couples in western Kenya. Cult Health Sex. 2016;18: 453–469. 10.1080/13691058.2015.1091507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Eliason S, Baiden F, Quansah-Asare G, Graham-Hayfron Y, Bonsu D, Phillips J, et al. Factors influencing the intention of women in rural Ghana to adopt postpartum family planning. Reprod Health. 2013;10: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ezeanolue EE, Iwelunmor J, Asaolu I, Obiefune MC, Ezeanolue CO, Osuji A, et al. Impact of male partner’s awareness and support for contraceptives on female intent to use contraceptives in southeast Nigeria. BMC Public Health. 2015;15: 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bawah AA. Spousal Communication and Family Planning Behavior in Navrongo: A Longitudinal Assessment. Stud Fam Plann. 2002;33: 185–194. 10.1111/j.1728-4465.2002.00185.x [DOI] [PubMed] [Google Scholar]
  • 30.Zimmerman L, Olson H, Tsui A, Radloff S. PMA2020: Rapid Turn-Around Survey Data to Monitor Family Planning Service and Practice in Ten Countries. Stud Fam Plann. 2017;48: 293–303. 10.1111/sifp.12031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pearson E, Becker S. Couples’ unmet need for family planning in three West African countries. Stud Fam Plann. 2014;45: 339–359. 10.1111/j.1728-4465.2014.00395.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Heck CJ, Grilo SA, Song X, Lutalo T, Nakyanjo N, Santelli JS. “It is my business”: A mixed-methods analysis of covert contraceptive use among women in Rakai, Uganda. Contraception. 2018;98: 41–46. 10.1016/j.contraception.2018.02.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Mackenzie A, S C, Speizer I, Callahan R, Martin S, Tolley E. The influences of partner opposition on women’s contraceptive use in East and West Africa. 2020.
  • 34.Choiriyyah I, Becker S. Measuring Women’s Covert Use of Modern Contraception in Cross-Sectional Surveys. Stud Fam Plann. 2018;49: 143–157. 10.1111/sifp.12053 [DOI] [PubMed] [Google Scholar]
  • 35.Baschieri A, Cleland J, Floyd S, Glynn JR, French N. Reproductive Preferences and Contraceptive Use: A Comparison of Monogamous and Polygamous Couples in Northern Malawi. J Biosoc Sci. 2013;45: 145–166. 10.1017/S0021932012000569 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Huber S, Garver S, Norris A. Does it matter if she’s right? Accurate perceptions of partner fertility desires on contraceptive use. 2017.
  • 37.Wolff B, Blanc AK, Ssekamatte-Ssebuliba J. The Role of Couple Negotiation in Unmet Need for Contraception and the Decision to Stop Childbearing in Uganda. Stud Fam Plann. 2000;31: 124–137. 10.1111/j.1728-4465.2000.00124.x [DOI] [PubMed] [Google Scholar]
  • 38.Koffi AK, Adjiwanou VD, Becker S, Olaolorun F, Tsui AO. Correlates of and Couples’ Concordance in Reports of Recent Sexual Behavior and Contraceptive Use. Stud Fam Plann. 2012;43: 33–42. 10.1111/j.1728-4465.2012.00300.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Becker S, Taulo FO, Hindin MJ, Chipeta EK, Loll D, Tsui A. Pilot study of home-based delivery of HIV testing and counseling and contraceptive services to couples in Malawi. BMC Public Health. 2014;14: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Harrington EK, McCoy EE, Drake AL, Matemo D, John-Stewart G, Kinuthia J, et al. Engaging men in an mHealth approach to support postpartum family planning among couples in Kenya: A qualitative study. Reprod Health. 2019;16: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Malama K, Kilembe W, Inambao M, Hoagland A, Sharkey T, Parker R, et al. A couple-focused, integrated unplanned pregnancy and HIV prevention program in urban and rural Zambia. Am J Obstet Gynecol. 2020; S915.e1–S915.e10. 10.1016/j.ajog.2020.01.007 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Kannan Navaneetham

9 Nov 2020

PONE-D-20-26947

The role of partner influence in contraceptive adoption, discontinuation, and switching in a nationally representative cohort of Ugandan women

PLOS ONE

Dear Dr. Sarnak,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 24 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Kannan Navaneetham, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include information about IRB approval in the manuscript as well.

3.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

5. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper adds to our further understanding about the important role that male partners play in reproductive health and contraceptive use. Although the findings are not surprising or new they do contribute to the literature - especially for those women who are non-contraceptive users.

I do have a few comments:

I would recommend for the authors to expand their literature review a bit.

Line 67-71 - Quite a bit of work (both quantitative and qualitative) is being done in the sub-Saharan setting about the involvement of male partners in contraceptive use. So I am not convinced that this statement holds very true.

Line 78-79 has a grammatical error. I think the word "use" is missing.

Line 78-81 - Please review the cited literature again. Some of the studies described in this paragraph actually does focus on the positive influence that male partners have on contraceptive use. Also, not all were framed to explore the male partner's influence as a barrier.

Analytical and Results section

I think the statistical and analytical section was well described and supported the findings.

One aspect that remains key in studies that examine male partner influence on contraceptive use is the fact that men are so often excluded from these studies. There is quite a large body of literature reporting women's perspectives on male involvement in contraceptive use - while the male perspective, or couple perspective, would add so much more clarity and understanding but is lacking. I do feel that this is where there is a silent gap in the DHS/large survey data and not really on the effect of the male partner on contraceptive use as reported by the female partner.

It is a pity about the large loss to follow-up rate.

Discussion

Only a small number of women (32.1%) started using contraception over the year follow up period. It is quite significant that such a small percentage of those women started contraceptive use without male partner support - which indicates just how important male partner support is in that setting.

Overall the findings were not surprising. It is well documented that communication plays a key role in contraceptive uptake and positive partner involvement. The results presented here support that. Probably the most interesting finding was that male partner influence seem to wane with increased contraceptive use by the female partner. This area needs further exploration, especially in the sub-Saharan region where patriarchal views still dominate. It is a bit of a concern that individual motivation could not be separated from partner influence.

Overall

I think this is a well written article with some important findings that adds to our understanding about male influence on contraceptive use.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Yolandie Kriel

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jan 12;16(1):e0238662. doi: 10.1371/journal.pone.0238662.r002

Author response to Decision Letter 0


8 Dec 2020

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include information about IRB approval in the manuscript as well.

We have the following text regarding IRB approval in the manuscript on page 7, line 151-154: “All data collection procedures were approved by Institutional Review Boards (IRBs) at the Makerere University School of Public Health (HDREC 081) and Uganda National Council for Science and Technology (SS3400) in Kampala, Uganda, and the Johns Hopkins Bloomberg School of Public Health in Baltimore, USA.” Please let us know if additional information is needed.

3.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Apologies for the confusion. PMA uses the same model as other publicly available datasets such as DHS; de-identified data is accessible to the public from https://www.pmadata.org/data/available-datasets through a registration process. We revised the language on the submission portal to: “Data for this study are publicly available at https://www.pmadata.org/data/available-datasets. Data are free to download and use; users are required to register for a PMA dataset account. The specific datasets used in this study are the Uganda Round 6 (2018) Household & Female survey and the Uganda Round 6 Follow-up (2019) Household & Female survey. The DOI for Uganda Round 6 (“baseline”) is doi: 10.34976/D41K-SH61 and the DOI for Uganda Round 6 Follow Up (“follow-up”) is doi: 10.34976/9x2b-nd72.”

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

There are no ethical or legal restrictions on sharing the de-identified dataset.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

PMA provides data to the public via request at https://www.pmadata.org/data/available-datasets. This URL should suffice for the stable, public repository PLOS One requires. The DOI for Uganda Round 6 (“baseline”) is doi: 10.34976/D41K-SH61 and the DOI for Uganda Round 6 Follow Up (“follow-up”) is doi: 10.34976/9x2b-nd72.

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

We revised the text to read “results not shown.” We conducted a sensitivity analyses that included a covariate for method type (short acting vs long acting method). We decided against adding another table or supporting information files to show these results given that the inferences remained the same. The results we refer to come from the public access dataset that we refer to above. Please let us know if we misunderstood this requirement.

5. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

We copied and pasted the abstract from the manuscript to the online submission form and they are now identical.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

We added the necessary captions for our supporting information file at the end of the manuscript, as described in the guidelines.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper adds to our further understanding about the important role that male partners play in reproductive health and contraceptive use. Although the findings are not surprising or new they do contribute to the literature - especially for those women who are non-contraceptive users.

I do have a few comments:

I would recommend for the authors to expand their literature review a bit.

Line 67-71 - Quite a bit of work (both quantitative and qualitative) is being done in the sub-Saharan setting about the involvement of male partners in contraceptive use. So I am not convinced that this statement holds very true.

Thank you for this suggestion. We have revised the introduction to include more of the literature on partner involvement and family planning in the region. Specifically, we have expanded the paragraph on positive influences that male partners can play in family planning on page 4, line 93. We highlight how male support can increase women’s intention to use family planning in the future, how male partners can facilitate access to facilities, adherence to methods, and how spousal communication has been linked prospectively with contraceptive use. We have also clarified the specific gap that our study fills in the research on page 5, line 111 : “Given the importance of gender and partner dynamics in reproductive decision-making, this study seeks to understand the predictive effect of partner influences, including partner’s support for contraception, discussions with partners about avoiding pregnancy prior to use, and perceived partner’s fertility intentions, on women’s contraceptive use dynamics (adoption, discontinuation, and switching) over a one-year period in a nationally representative sample in Uganda.”

Line 78-79 has a grammatical error. I think the word "use" is missing.

Thank you for catching this typo, we have updated the sentence with the word “use” on line 79.

Line 78-81 - Please review the cited literature again. Some of the studies described in this paragraph actually does focus on the positive influence that male partners have on contraceptive use. Also, not all were framed to explore the male partner's influence as a barrier.

Thank you for pointing this out. Upon revisiting the papers cited in that paragraph, we have revised the introduction to include a paragraph that focuses on the specific supportive roles male partners can play in family planning and contraception, lines 93-109.

Analytical and Results section

I think the statistical and analytical section was well described and supported the findings.

One aspect that remains key in studies that examine male partner influence on contraceptive use is the fact that men are so often excluded from these studies. There is quite a large body of literature reporting women's perspectives on male involvement in contraceptive use - while the male perspective, or couple perspective, would add so much more clarity and understanding but is lacking. I do feel that this is where there is a silent gap in the DHS/large survey data and not really on the effect of the male partner on contraceptive use as reported by the female partner.

We agree. One limitation of our study, which we mention in the discussion, is that our measures of male partners’ characteristics, e.g. their fertility intentions and their support for contraception, are reported by women respondents. Therefore, these proxy-reported indicators may differ from how male partners would respond to survey items. We conclude by calling for the inclusion of men in future research on contraceptive use and reproductive health more broadly.

It is a pity about the large loss to follow-up rate.

We agree that the large loss-to-follow-up is not ideal; however, we feel that our loss-to-follow up weights did restore our panel sample to reflect the original sample in terms of key demographic variables. There could be unobserved differences and we state this as our primary limitation to the study.

Discussion

Only a small number of women (32.1%) started using contraception over the year follow up period. It is quite significant that such a small percentage of those women started contraceptive use without male partner support - which indicates just how important male partner support is in that setting.

Thank you for this suggestion; we have called out the percentage difference in the percent of non-users that adopted with and without partner support in the discussion on line 389-390.

Overall the findings were not surprising. It is well documented that communication plays a key role in contraceptive uptake and positive partner involvement. The results presented here support that. Probably the most interesting finding was that male partner influence seem to wane with increased contraceptive use by the female partner. This area needs further exploration, especially in the sub-Saharan region where patriarchal views still dominate. It is a bit of a concern that individual motivation could not be separated from partner influence.

We agree that there are nuances we were not able to capture in this study, e.g. comparing a woman’s own motivation to avoid pregnancy or use contraception to the influence of her partners. In an effort to address this, we restricted the sample of women to those who wanted to avert a pregnancy during the study period, so that they were all “at risk” of unintended pregnancy. Unfortunately, we do not have a way to measure the strength of their motivation to avoid pregnancy, and therefore cannot disentangle it from their reports of partner support. Further, this construct may not make sense among women who are currently users.

We also think that it is interesting that partner support was an important predictor of contraception adoption, yet current support of contraception was not predictive of discontinuation. We could not provide evidence-based explanations from our data, only postulations from other research. Further research should explore this in-depth as you suggest; specifically, identifying ways in which male partners can be supportive in adoption, continuation and switching, and whether and how these ways are similar or different.

Overall

I think this is a well written article with some important findings that adds to our understanding about male influence on contraceptive use.

Attachment

Submitted filename: Response to Reviewers_12082020.docx

Decision Letter 1

Kannan Navaneetham

10 Dec 2020

The role of partner influence in contraceptive adoption, discontinuation, and switching in a nationally representative cohort of Ugandan women

PONE-D-20-26947R1

Dear Dr. Sarnak,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Kannan Navaneetham, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Kannan Navaneetham

2 Jan 2021

PONE-D-20-26947R1

The role of partner influence in contraceptive adoption, discontinuation, and switching in a nationally representative cohort of Ugandan women

Dear Dr. Sarnak:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Kannan Navaneetham

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Comparison of baseline and follow-up samples with and without loss-to-follow-up weighting.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers_12082020.docx

    Data Availability Statement

    Data for this study are publicly available at https://www.pmadata.org/data/available-datasets. Data are free to download and use; users are required to register for a PMA dataset account. The specific datasets used in this study are the Uganda Round 6 (2018) Household & Female survey and the Uganda Round 6 Follow-up (2019) Household & Female survey.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES